Journal of Virology, April 2000, p. 3555-3565, Vol. 74, No. 8
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan 48109-0618,1 and Departments of Pediatrics2 and Pharmacology,3 University of North Carolina, Chapel Hill, North Carolina 27599
Received 1 September 1999/Accepted 18 January 2000
Recombinant adeno-associated virus (rAAV) vectors have been shown
to be useful for efficient gene delivery to a variety of dividing and
nondividing cells. Mechanisms responsible for the long-term, persistent
expression of the rAAV transgene are not well understood. In this study
we investigated the kinetics of rAAV-mediated human factor IX (hFIX)
gene transfer into human primary myoblasts and myotubes. Transduction
of both myoblasts and myotubes occured with a similar and high
efficiency. After 3 to 4 weeks of transduction, rAAV with a
cytomegalovirus (CMV) promoter showed 10- to 15-fold higher expression
than that with a muscle-specific creatine kinase enhancer linked to
-actin promoter. Factor IX expression from transduced myoblasts as
well as myotubes reached levels as high as approximately 2 µg of
hFIX/106 cells/day. Southern blot analyses of
high-molecular-weight (HMW) cellular genomic and Hirt DNAs isolated
from rAAV/CMVhFIXm1-transduced cells showed that the conversion of
single-stranded vector genomes to double-stranded DNA forms, but not
the level of the integrated forms in HMW DNA, correlated with
increasing expression of the transgene. Together, these results
indicate that rAAV can transduce both proliferating and terminally
differentiated muscle cells at about the same efficiency, that
expression of transgenes increases linearly over their lifetime with no
initial lag phase, and that increasing expression correlates with the
appearance of double-stranded episomal rAAV genomes. Evidence showing
that the rAAV virions can copackage hFIX, presumably nonspecifically,
was also obtained.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|